Irving’s McKesson said it will acquire an 80% interest in the provider of general ophthalmology and retina management services. PRISM Vision physicians will continue to retain a 20% interest in their company.
“The acquisition of PRISM Vision will allow McKesson to build on our leadership in community practice and specialty solutions, while building a platform to serve the high-growth area of retina and ophthalmology,” McKesson CEO Brian Tyler said in a statement. “PRISM Vision has a strong track record and value proposition for community-based physicians and a strong leadership team focused on delivering superior retinal care, enhancing the provider experience and delivering innovative clinical research capabilities.”
The deal is expected to deliver on several key objectives, including:
- Develop a leading retinal and ophthalmology platform, expanding McKesson’s differentiated value proposition, clinical services and distribution offerings. PRISM affiliated practices include more than 180 providers, 91 office locations and seven ambulatory surgery centers
- Expand data and analytics capabilities
- Further innovative investment in clinical research opportunities
- Deepen biopharma partnerships
Read the full story on Dallas Innovates.
